Effect of online hemodiafiltration on morbidity and mortality of chronic kidney disease patients

Contributions to Nephrology

Volumn 158, Issue , 2007, Pages 216-224

  Canaud, Bernard ^a,b  

^a LAPEYRONIE HOSPITAL   (France)

^b UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHRONIC KIDNEY FAILURE; HEMODIAFILTRATION; HUMAN; METHODOLOGY; MORBIDITY; MORTALITY; ONLINE SYSTEM; STANDARD; SURVIVAL RATE;

HEMODIAFILTRATION; HUMANS; KIDNEY FAILURE, CHRONIC; MORBIDITY; ONLINE SYSTEMS; SURVIVAL RATE;

EID: 34547968778     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/0000107253     Document Type: Article

References (62)

1. Henderson LW: Dialysis in the 21st century. Am J Kidney Dis 1996;28:951-957.
2. Clark WR, Gao D. Low-molecular weight proteins in end-stage renal disease: potential toxicity and dialytic removal mechanisms. J Am Soc Nephrol 2002;13:S41-S47.
3. Vanholder R, Glorieux G, De Smet R, et al: New insights in uremic toxins. Kidney Int Suppl 2003;84:S6.
4. Vanholder R, Glorieux GL, De Smet R: Back, to the future: middle molecules, high flux membranes, and optimal dialysis. Hemodial Int 2003;7:52.
5. Henderson LW, Clark WR, Cheung AK: Quantification of middle molecular weight solute removal in dialysis. Semin Dial 2001;14:294-299.
6. Leypoldt JK, Cheung AK, Carroll CE, Stannard DC, Pereira BJ, Agodoa LY, Port FK: Effect of dialysis membranes and middle molecule removal on chronic hemodialysis patient survival. Am J Kidney Dis 1999;33:349-355.
7. Canaud B, Bosc JY, Leray-Moragues H, Stec F, Argiles A, Leblanc M, Mion C: On-line haemodiafiltration: safety and efficacy in long-term clinical practice. Nephrol Dial Transplant 2000;15(suppl 1):60-67.
8. Canaud B, Bosc JY, Leblanc M, Garred LJ, Vo T, Mion C. Evaluation of high-flux hemodiafiltration efficiency using an on-line urea monitor. Am J Kidney Dis 1998;31:74-80.
9. Maduell F: Hemodiafiltration. Hemodial Int 2005;9:47-55.
10. Shinzato T, Kobayakawa H, Maeda K: Comparison of various treatment modes in terms of beta 2-microglobulin removal: hemodialysis, hemofiltration, and push/pull HDF. Artif Organs 1989;13:66-70.
11. Lornoy W, De Meester J, Becaus I, Billiouw JM, Van Malderen PA, Van Pottelberge M. Impact of convective flow on phosphorus removal in maintenance hemodialysis patients. J Ren Nutr 2006;16:47-53.
12. Zehnder C, Gutzwiller JP, Renggli K: Hemodiafiltration - A new treatment option for hyperphosphatemia in hemodialysis patients. Clin Nephrol 1999;52:152.
13. Krieter DH, Lemke HD, Canaud B, Wanner C: Beta-2-microglobulin removal by extracorporeal renal replacement therapies. Biochim Biophys Acta 2005;1753:146-153.
14. Ward RA, Greene T, Hartmann B, Samtleben W. Resistance to intercompartmental mass transfer limits beta2-microglobulin removal by post-dilution hemodiafiltration. Kidney Int 2006;69:1431-1437.
15. Lornoy W, Becaus I, Billiouw JM, et al: On-line haemodiafiltration: remarkable removal of beta2-microglobulin - Long-term clinical observations. Nephrol Dial Transplant 2000;15(suppl 1):49.
16. Locatelli F, Mastrangelo F, Redaelli B, et al: Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters. The Italian Cooperative Dialysis Study Group. Kidney Int 1996;50:1293.
17. Basile C: The effect of convection on the nutritional status of haemodialysis patients. Nephrol Dial Transplant 2003;18(suppl 7):vii46-49.
18. Altieri P, Sorba G, Bolasco P, Ledebo I, Ganadu M, Ferrara R, Menneas A, Asproni E, Casu D, Passaghe M, Sau G, Cadinu F, Sardinian Study Group on Hemofiltration On-line. Related comparison between hemofiltration and hemodiafiltration in a long-term prospective cross-over study. J Nephrol 2004;17:414-422.
19. Donauer J, Schweiger C, Rumberger B, Krumme B, Bohler J: Reduction of hypotensive side effects during online-haemodiafiltration and low temperature haemodialysis. Nephrol Dial Transplant 2003;18:1616-1622.
20. van der Sande FM, Rosales LM, Brener Z, Kooman JP, Kuhlmann M, Handelman G, Greenwood RN, Carter M, Schneditz D, Leunissen KM, Levin NW: Effect of ultrafiltration on thermal variables, skin temperature, skin blood flow, and energy expenditure during ultrapure hemodialysis. J Am Soc Nephrol 2005;16:1824-1831.
21. Maduell F, del Pozo C, Garcia H, Sanchez L, Hdez-Jaras J, Albero MD, Calvo C, Torregrosa I, Navarro V: Change from conventional haemodiafiltration to on-line haemodiafiltration. Nephrol Dial Transplant 1999;14:1202-1207.
22. Stegmayr BG: Ultrafiltration and dry weight - What are the cardiovascular effects? Artif Organs 2003;27:227-229.
23. Maduell F, Navarro V, Torregrosa E, Rius A, Dicenta F, Cruz MC, Ferrero JA: Change from three times a week on-line hemodiafiltration to short daily on-line hemodiafiltration. Kidney Int 2003;64:305-313.
24. McKane W, Chandna SM, Tattersall JE, et al: Identical decline of residual renal function in high-flux biocompatible hemodialysis and CAPD. Kidney Int 2002;61:256.
25. Pozzoni P, Filippo S, Manzoni C, Locatelli F: The relevance of convection in clinical practice: a critical review of the literature. Hemodial Int 2006;10(suppl 1):S33-S38.
26. van Tellingen A, Grooteman MP, Schoorl M, et al: Intercurrent, clinical events are predictive of plasma C-reactive protein levels in hemodialysis patients. Kidney Int 2002;62:632.
27. Canaud B, Wizemann V, Pizzarelli F, et al: Cellular interleukin-1 receptor antagonist production in patients receiving on-line haemodiafiltration therapy. Nephrol Dial Transplant 2001;16:2181.
28. Olsson J, Dadfar E, Paulsson J, Lundahl J, Moshfegh A, Jacobson SH: Preserved, leukocyte CD11b expression at the site of interstitial inflammation in patients with high-flux hemodiafiltration. Kidney Int 2007;71:582-588.
29. Carracedo J, Merino A, Nogueras S, Carretero D, Berdud I, Ramirez R, Tetta C, Rodriguez M, Martin-Malo A, Aljama P: On-line hemodiafiltration reduces the proinflammatory CD14 + CD16 + monocyte-derived dendritic cells: a prospective, crossover study. J Am Soc Nephrol 2006;17:2315-2321.
30. Ramirez R, Carracedo J, Merino A, Nogueras S, Alvarez-Lara MA, Rodriguez M, Martin-Malo A, Tetta C, Aljama P. Microinflammation induces endothelial damage in hemodialysis patients: the role of convective transport. Kidney Int 2007, E-pub ahead of print.
31. Deppisch RM, Beck W, Goehl H, et al: Complement components as uremic toxins and their potential role as mediators of microinflammation. Kidney Int. Suppl 2001;78:S271.
32. Vaslaki L, Major L, Berta K, Karatson A, Misz M, Pethoe F, Ladanyi E, Fodor B, Stein G, Pischetsrieder M, Zima T, Wojke R, Gauly A, Passlick-Deetjen J: On-line haemodiafiltration versus haemodialysis: stable haematocrit with less erythropoietin and improvement of other relevant blood parameters. Blood Purif 2006;24:163-173.
33. Schiffl H, Lang SM, Stratakis D, et al: Effects of ultrapure dialysis fluid on nutritional status and inflammatory parameters. Nephrol Dial Transplant 2001;16:1863.
34. Lindsay RM, Spanner E, Heidenheim AP, et al: A multicenter study of short hour dialysis using AN69S: preliminary results. ASAIO Trans 1991;37:M465.
35. Savica V, Ciolino F, Monardo P, Mallamace A, Savica R, Santoro D, Bellinghieri G: Nutritional status in hemodialysis patients: options for on-line convective treatment. J Ren Nutr 2006;16:237-240.
36. Blankestijn PJ, Vos PF, Rabelink TJ, et al: High-flux dialysis membranes improve lipid profile in chronic hemodialysis patients. J Am Soc Nephrol 1995;5:1703.
37. Chun-Liang L, Chiu-Ching H, Chun-Chen Y, et al: Reduction of advanced glycation end products levels by on-line hemodiafiltration in long-term hemodialysis patients. Am J Kidney Dis 2003;42:524.
38. Calo LA, Naso A, Carraro G, Wratten ML, Pagnin E, Bertipaglia L, Rebeschini M, Davis PA, Piccoli A, Cascone C: Effect of haemodiafiltration with online regeneration of ultrafiltrate on oxidative stress in dialysis patients. Nephrol Dial Transplant 2007, E-pub ahead of print.
39. Ward RA, McLeish KR: Oxidant stress in hemodialysis patients: what are the determining factors? Artif Organs 2003;27:230.
40. Morena M, Cristol JP, Bosc JY, et al: Convective and diffusive losses of vitamin C during haemodiafiltration session: a contributive factor to oxidative stress in haemodialysis patients. Nephrol Dial Transplant 2002;17:422.
41. Kalousova M, Kielstein JT, Hodkova M, Zima T, Dusilova-Sulkova S, Martens-Lobenhoffer J, Bode-Boger SM: No benefit of hemodiafiltration over hemodialysis in lowering elevated levels of asymmetric dimethylarginine in ESRD patients. Blood Purif 2006;24:439-444.
42. Locatelli F, Manzoni C, Di Filippo S: The importance of convective transport. Kidney Int Suppl 2002;80:115.
43. Lonnemann G, Koch KM: Beta(2)-microglobulin amyloidosis: effects of ultrapure dialysate and type of dialyzer membrane. J Am Soc Nephrol 2002;13(suppl 1):S72.
44. Fischbach M, Terzic J, Laugel V, Dheu C, Menouer S, Helms P, Livolsi A: Daily on-line haemodiafiltration: a pilot trial in children. Nephrol Dial Transplant 2004;19:2360-2367.
45. Fischbach M, Terzic J, Menouer S, Dheu C, Soskin S, Helmstetter A, Burger MC: Intensified and daily hemodialysis in children might improve statural growth. Pediatr Nephrol. 2006;21:1746-1752.
46. Kari JA, Rees L: Growth hormone for children with chronic renal failure and on dialysis. Pediatr Nephrol 2005;20:618-621.
47. Boehm M, Riesenhuber A, Winkelmayer WC, Arbeiter K, Mueller T, Aufricht C: Early erythropoietin therapy is associated with improved growth in children with chronic kidney disease. Pediatr Nephrol 2007, E-pub ahead of print.
48. Locatelli F, Pozzoni P, Manzoni C, Di Filippo S: High-flux hemodialysis and hemodiafiltration: impact on outcome; in Ronco C, La Greca G (eds): Hemodialysis Technology. Contrib Nephrol. Basel, Karger, 2002, vol 137, pp 193-200.
49. Locatelli F, Marcelli D, Conte F, Limido A, Malberti F, Spotti D. Comparison of mortality in ESRD patients on convective and diffusive extracorporeal treatments. The Registro Lombardo Dialisi E Trapiento. Kidney Int 1999;55:286-293.
50. Port FK, Wolfe RA, Hulbert-Shearon TE, Daugirdas JT, Agodoa LY, Jones C, Orzol SM, Held PJ: Mortality risk by hemodialyzer reuse practice and dialyzer membrane characteristics: results from the USRDS dialysis morbidity and mortality study. Am J Kidney Dis 2001;37:276-286.
51. Chauveau P, Nguyen H, Combe C, Chene G, Azar R, Cano N, Canaud B, Fouque D, Laville M, Leverve X, Roth H, Aparicio M, French Study Group for Nutrition in. Dialysis: Dialyzer membrane permeability and survival in hemodialysis patients. Am J Kidney Dis 2005;45:565-571.
52. Eknoyan G, Beck GJ, Cheung AK, et al: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002;19:347.
53. Santoro A, Panzetta G, Tessitore N, Atti M, Mancini E, Esteban J, London G, Ara JM, Miguel JL, Neumann KH, Opatrny K, Perez R, Perrone B, Wizemann V, Zucchelli P: A prospective randomised European multicentre study of medium-long run mortality and morbidity comparing acetate-free biofiltration and bicarbonate dialysis. J Nephrol 1999;12:375-382.
54. Wizemann V, Lotz C, Techert F, Uthoff S: On-line haemodiafiltration versus low-flux haemodialysis: a prospective randomized study. Nephrol Dial Transplant 2000;15(suppl 1):43-48.
55. Schiffl H. Prospective randomized cross-over long-term comparison of online haemodiafiltration and ultrapure high-flux haemodialysis. Eur J Med Res 2007;12:26-33.
56. Eknoyan G, Beck GJ, Cheung AK, et al: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002;19:347.
57. Cheung AK, Rocco MV, Yan G, Leypoldt JK, Levin NW, Greene T, Agodoa L, Bailey J, Beck GJ, Clark W, Levey AS, Ornt DB, Schulman G, Schwab S, Teehan B, Eknoyan G: Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. J Am Soc Nephrol 2006;17:546-555.
58. Canaud B, Bragg-Gresham JL, Marshall MR, Desmeules S, Gillespie BW, Depner T, Klassen P, Port FK: Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS. Kidney Int 2006;69:2087-2093.
59. Jirka T, Cesare S, Di Benedetto A, Perera Chang M, Ponce P, Richards N, Tetta C, Vaslaky L: Mortality risk for patients receiving hemodiafiltration versus hemodialysis. Kidney Int 2006;70:1524.
60. Bosch JP, Lew SQ, Barlee V, Mishkin GJ, von Albertini B: Clinical use of high-efficiency hemodialysis treatments: long-term assessment. Hemodial Int 2006;10:73-81.
61. Canaud B, Morena M, Leray-Moragues H, Chalabi L, Cristol JP: Overview of clinical studies in hemodiafiltration: what do we need now? Hemodial Int 2006;10(suppl 1):S5-S12.
62. Penne EL, Blankestijn PJ, Bots ML, van den Dorpel MA, Grooteman MP, Nube MJ, ter Wee PM, CONTRAST Group: Resolving controversies regarding hemodiafiltration versus hemodialysis: the Dutch Convective Transport Study. Semin Dial 2005;18:47-51.